2023
DOI: 10.1016/j.bj.2022.08.005
|View full text |Cite
|
Sign up to set email alerts
|

Hypocalcemia: A key biomarker in hospitalized COVID-19 patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 35 publications
0
2
0
Order By: Relevance
“…The alteration of calcium represents one of the important parameters of viral infection, with hypocalcemia being associated with the presence of cardiac comorbidities, hospitalization in a clinical ward, mechanical ventilation, superinfection, thrombosis risk, and an unfavorable prognosis, independent of vitamin D or parathormone [51]. Studies have shown that decreased serum calcium levels were present in patients who developed less severe forms of viral infection with the novel coronavirus [52].…”
Section: Discussionmentioning
confidence: 99%
“…The alteration of calcium represents one of the important parameters of viral infection, with hypocalcemia being associated with the presence of cardiac comorbidities, hospitalization in a clinical ward, mechanical ventilation, superinfection, thrombosis risk, and an unfavorable prognosis, independent of vitamin D or parathormone [51]. Studies have shown that decreased serum calcium levels were present in patients who developed less severe forms of viral infection with the novel coronavirus [52].…”
Section: Discussionmentioning
confidence: 99%
“…Due to their ability to miniaturise laboratory processes and physiological functions on microdevices, both microfluidic technologies are at the forefront of biomedical research and diagnostics [3], driving demand for customised medical devices [4]. Certainly, the COVID-19 pandemic, alongside vaccination campaigns and the investigation of biological markers to identify subjects at an elevated risk of hospitalisation [5,6], has accelerated the translation of microfluidic solutions from laboratory to commercial applications through LOC devices for point-of-care [7,8]. In this context, several technologies have been developed and their applications have been extended to various medical fields [9,10], but microfluidics has emerged as a key technology in translating proof of concepts from research laboratories to commercial applications [11].…”
Section: Introductionmentioning
confidence: 99%